vasopressin antagonists (Lilly/Competitive Technologies)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namevasopressin antagonists (Lilly/Competitive Technologies)
Drug Alias Nameoxytocin antagonists (Lilly/Competitive Technologies)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOxytocin receptor antagonistsVasopressin V2 receptor antagonists
TargetsOxytocin receptorVasopressin V2 receptor
Therapy Area/IndicationsObsessive-Compulsive DisorderAnxiety DisordersDepression +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCalmare Therapeutics IncEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsObsessive-Compulsive DisorderAnxiety DisordersDepression +[5] 

Other Information

ATC CodeN/A
Related LinksN/A